Impact of Covid-19 pandemic on injection-based practice: report from an Italian multicenter and multidisciplinary survey
Keywords:
COVID-19, SARS-CoV-2, musculoskeletal diseases, intra-articular therapy, hyaluronic acid, corticosteroidsAbstract
Background. There are no papers exploring the impact of COVID-19 pandemic on the injection-based practice in patients affected by different rheumatic diseases, including osteoarthritis. The aim was to investigate the impact of COVID-19 pandemic on injection-based practice trough the Italian country.
Study design. A survey-based retrospective cross-sectional study
Methods. An Italian-language questionnaire was developed by a group of senior researchers and distributed by e-mail to some Rheumatology, Orthopedic and Rehabilitation Units from different geographic areas of Italy. The survey included information about the number of injections performed during COVID-19 pandemic (stratified by injected agents and injected joint), in comparison to the pre-pandemic period, and the possible reasons behind an eventual reduction. Responses were collected and descriptive analysis calculated.
Results. Eleven centers of the National Health Service completed the survey. The activities of the injections services significantly decreased across the country with a percentage of reduction of 60% compared to the pre-pandemic period. A significant reduction of both intra-articular and peri-articular injections was registered. Among intra-articular. treatments, the most affected ones were the hyaluronic acid injections, when compared to corticosteroids. A significant decrease of the total amount of peri-articular injections was observed. The strict government restrictions and the fear of patients to become infected represented the most limiting factors.
Conclusions. The reported decrease of the injection-based practice in our country during the COVID-19 pandemic highlights the detrimental effects of the COVID-19 pandemic on the management of chronic musculoskeletal diseases with possible negative consequences in terms of disability and quality of life.
References
1. Rosenbaum L. Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic’s Front Line. N Engl J Med. 2020 May 14; 382(20): 1873-75. doi: 10.1056/NEJMp2005492.
2. World Health Organization (WHO). WHO Coronavirus Disease (COVID-19) Dashboard. 2020. Available on: https://covid19.who.int [Last accessed: 2021 June 8].
3. Centers for Medicare and Medicaid Services (CMC). Non-emergent, elective medical services, and treatment recommendations. 2020. Available on: https://www.cms.gov/files/ document/cms-non-emergent-elective-medicalrecommendations.pdf [Last accessed: 2021 June 8].
4. Bettinsoli ML, Di Riso D, Napier JL, et al. Mental Health Conditions of Italian Healthcare Professionals during the COVID-19 Disease Outbreak. Appl Psychol Health Well Being. 2020 Dec; 12(4): 1054-73. doi: 10.1111/ aphw.12239.
5. Moretti L, Bizzoca D, Vitale E, et al. Gender and Socio-Economic Issues in the Clinical Assessment of Orthopaedic Patients During the COVID19 Pandemic. Preprints 2021, 2021030089. doi:
10.20944/preprints202103.0089.v1.
6. Boldrini P, Bernetti A, Fiore P; SIMFER Executive Committee, SIMFER Committee for International Affairs. Impact of COVID-19 outbreak on rehabilitation services and Physical and Rehabilitation Medicine physicians’ activities in Italy. An official document of the Italian PRM Society (SIMFER). Eur J Phys Rehabil Med. 2020 Jun; 56(3):316-318. doi: 10.23736/ S1973-9087.20.06256-5.
7. Landewé RB, Machado PM, Kroon F, et al. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2. Ann Rheum Dis. 2020 Jul; 79(7): 851-8. doi: 10.1136/annrheumdis-2020-217877.
8. Perniola S, Alivernini S, Varriano V, et al.
Telemedicine will not keep us apart in COVID19 pandemic. Ann Rheum Dis. 2020 Jun 5: annrheumdis-2020-218022. doi: 10.1136/ annrheumdis-2020-218022.
9. Santos-Moreno P, Chavez-Chavez J, HernándezZambrano SM, et al. Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic. Ann Rheum Dis. 2020 Jun 25: annrheumdis-2020218165. doi: 10.1136/annrheumdis-2020218165.
10. Agostini F, Mangone M, Ruiu P, Paolucci T, Santilli V, Bernetti A. Rehabilitation setting during and after Covid-19: An overview on recommendations. J Rehabil Med. 2021 Jan 5; 53(1):
jrm00141. doi: 10.2340/16501977-2776.
11. Dejaco C, Alunno A, Bijlsma JW, et al. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Ann Rheum Dis. 2020 Nov 6: annrheumdis-2020-218697. doi: 10.1136/annrheumdis-2020-218697. Epub ahead of print.
12. Bai AV, Rabasco J, Ceccatelli V, et al. Suggestions for changes in professional procedures and adaptation to COVID-19: new models of care in the rehabilitation setting. Ann Ig. 2021 May-Jun; 33(3): 299-304. doi: 10.7416/ai.2021.2434.
13. Masiero S, Maccarone MC, Agostini F. Health resort medicine can be a suitable setting to recover disabilities in patients tested negative for COVID-19 discharged from hospital? A challenge for the future. Int J Biometeorol. 2020 Oct; 64(10): 1807-9. doi: 10.1007/s00484-02001947-4.
14. Jones IA, Togashi R, Wilson ML, Heckmann N, Vangsness CT Jr. Intra-articular treatment options for knee osteoarthritis. Nat Rev Rheumatol. 2019 Feb; 15(2): 77-90. doi: 10.1038/ s41584-018-0123-4.
15. Evans CH, Kraus VB, Setton LA. Progress in intra-articular therapy. Nat Rev Rheumatol. 2014 Jan; 10(1): 11-22. doi: 10.1038/ nrrheum.2013.159. Epub 2013 Nov 5.
16. Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019 Nov; 27(11): 1578-89. doi: 10.1016/j.joca.2019.06.011.
17. Bruyère O, Honvo G, Veronese N, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019 Dec; 49(3): 337-50. doi: 10.1016/j.semarthrit.2019.04.008.
18. Rausch Osthoff AK, Niedermann K, Braun J, et al. 2018 EULAR recommendations for physical activity in people with inflammatory arthritis and osteoarthritis. Ann Rheum Dis. 2018 Sep; 77(9): 1251-60. doi: 10.1136/annrheumdis2018-213585.
19. Kingsbury SR, Gross HJ, Isherwood G, Conaghan PG. Osteoarthritis in Europe: impact on health status, work productivity and use of pharmacotherapies in five European countries. Rheumatology (Oxford). 2014 May; 53(5): 93747. doi: 10.1093/rheumatology/ket463.
20. Voiriot G, Philippot Q, Elabbadi A, Elbim C, Chalumeau M, Fartoukh M. Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients. J Clin Med. 2019 Jun 3; 8(6): 786. doi: 10.3390/jcm8060786.
21. Ragni E, Mangiavini L, Viganò M, et al. Management of Osteoarthritis During the COVID19 Pandemic. Clin Pharmacol Ther. 2020 Oct; 108(4): 719-29. doi: 10.1002/cpt.1910.
22. Bernetti A, Agostini F, Alviti F, et al. New Viscoelastic Hydrogel Hymovis MO.RE. Single Intra-articular Injection for the Treatment of Knee Osteoarthritis in Sportsmen: Safety and Efficacy Study Results. Front Pharmacol. 2021 May 28; 12: 673988. doi: 10.3389/fphar.2021.673988.
23. Bernetti A, Mangone M, Paolucci T, et al. Evaluation of the efficacy of intra-articular injective treatment with reticular hyaluronic acid (Mo.Re. Technology) in amateur athletes with over-use gonarthrosis. Med Sport. 2020 Mar; 73(1): 12739. doi: 10.23736/S0025-7826.20.03648-0.
24. Youssef J, Novosad SA, Winthrop KL. Infection Risk and Safety of Corticosteroid Use. Rheum Dis Clin North Am. 2016 Feb; 42(1): 157-76, ix-x. doi: 10.1016/j.rdc.2015.08.004.
25. Habib GS. Systemic effects of intra-articular corticosteroids. Clin Rheumatol. 2009 Jul; 28(7): 749-56. doi: 10.1007/s10067-009-1135-x.
26. Sytsma TT, Greenlund LK, Greenlund LS. Joint Corticosteroid Injection Associated With Increased Influenza Risk. Mayo Clin Proc Innov Qual Outcomes. 2018 Mar 20; 2(2):194-8. doi:
10.1016/j.mayocpiqo.2018.01.005.
27. Little CP, Birks ME, Horwitz MD, Ng CY, Warwick D. COVID-19: A rethink of corticosteroid injection? Bone Jt Open. 2020 Jun 11; 1(6): 253-6. doi: 10.1302/2633-1462.16.BJO-20200050.R1.
28. British Society for Rheumatology, British Association of Orthopaedics, British Association of Spinal Surgeons, Royal College of General Practitioners, British Society of Interventional Radiology, Faculty of Pain Medicine, British Pain Society and Chartered Society of Physiotherapy. Management of patients with musculoskeletal and rheumatic conditions who: - are on corticosteroids -require initiation of oral/IV corticosteroids - require a corticosteroid injection. 2020. Available on: https://www.rheumatology.org.uk/Portals/0/Documents/COVID19/ MSK_rheumatology_corticosteroid_guidance.
pdf [Last accessed: 2021 June 8].
29. McKean D, Chung SL, Fairhead R, et al.
Corticosteroid injections during the COVID19 pandemic: experience from a UK centre. Bone Jt Open. 2020 Sep 28; 1(9): 605-11. doi:
10.1302/2633-1462.19.BJO-2020-0130.R1.
30. Newton AC, Jones G, Jones JWM, Norris R, Barabas AG. Intra-articular corticosteroid injections during the COVID-19 lockdown period: A service evaluation. Musculoskeletal Care. 2021 Jun; 19(2): 236-43. doi: 10.1002/msc.1530. Epub 2020 Dec 5.
31. Oliva F, Vittadini F, Frizziero A, et al. I.S.Mu.L.T. Reccomendations for Intra and Periarticular Injections during COVID-19 Pandemic. Muscles Ligaments Tendons J. 2020 Jul-Sep; 10(3): 343-6.
https://doi.org/10.32098/mltj.03.2020.00.
32. Leifer VP, Katz JN, Losina E. The burden of OAhealth services and economics. Osteoarthritis Cartilage. 2022 Jan; 30(1): 10-6. doi: 10.1016/j.
joca.2021.05.007. Epub 2021 May 20.
33. Colombo GL, Heiman F, Peduto I. Utilization of Healthcare Resources in Osteoarthritis: A Cost of Illness Analysis Based on Real-World Data in Italy. Ther Clin Risk Manag. 2021 Apr 21; 17:
345-56. doi: 10.2147/TCRM.S301005.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.